Compile Data Set for Download or QSAR
maximum 50k data
Found 32 Enz. Inhib. hit(s) with all data for entry = 50011879
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111656(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.230nMAssay Description:Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111644(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.590nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111645(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.590nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111645(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.700nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111646(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.710nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111647(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.850nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111641(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  0.890nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111650(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.10nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111650(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.20nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111649(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.30nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111651(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.40nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111654(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.40nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111641(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.40nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111647(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.5nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111643(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.70nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111644(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111654(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.30nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111642(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.30nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111649(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.60nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111642(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.60nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111648(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.80nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111643(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  2.90nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111657(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  3.30nMAssay Description:Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptor at a concentration of 10e-6...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111655(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  3.80nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111652(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  4.40nMAssay Description:Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111651(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  4.70nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111655(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  4.70nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111653(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  6.10nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111653(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  9nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111648(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  10nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with Human NPY-Y5 cDNA (compound prepared by manual s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50111646(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  17nMAssay Description:Inhibitory concentration of total specific binding of [125I]- -PYY to HEK 293 cells transfected with the Human NPY-Y5 cDNA (compound prepared by para...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110568(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  53nMAssay Description:Tested for the inhibition of [125I]-PYY binding to HEK 293 cells stably expressed with human neuropeptide NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed